Corbus Pharmaceuticals Reports 2015 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Corbus Pharma (CRBP) Tops Q3 EPS by 2c
November 11, 2015 7:33 AM ESTCorbus Pharma (NASDAQ: CRBP) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
Expected Near-Term Milestones
Continue to screen and enroll patients in both the Phase 2 studies in CF and in systemic sclerosis to remain on track... More